246 related articles for article (PubMed ID: 17927878)
1. [Expression and exon 3 mutation of beta-catenin in human hepatocellular carcinoma].
Jiao Y; Ban KC; Cao J; Yue HY; Luo Y; Su JJ
Ai Zheng; 2007 Oct; 26(10):1085-9. PubMed ID: 17927878
[TBL] [Abstract][Full Text] [Related]
2. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
3. GSK-3beta phosphorylation and alteration of beta-catenin in hepatocellular carcinoma.
Ban KC; Singh H; Krishnan R; Seow HF
Cancer Lett; 2003 Sep; 199(2):201-8. PubMed ID: 12969793
[TBL] [Abstract][Full Text] [Related]
4. β-catenin plays a key role in metastasis of human hepatocellular carcinoma.
Lai TY; Su CC; Kuo WW; Yeh YL; Kuo WH; Tsai FJ; Tsai CH; Weng YJ; Huang CY; Chen LM
Oncol Rep; 2011 Aug; 26(2):415-22. PubMed ID: 21617877
[TBL] [Abstract][Full Text] [Related]
5. PIN1 gene overexpression and beta-catenin gene mutation/expression in hepatocellular carcinoma and their significance.
Wang H; Zhang J; Feng W; Zhang S; Liang H; Wang Y; Zheng Q; Li Z
J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):54-7. PubMed ID: 17393110
[TBL] [Abstract][Full Text] [Related]
6. Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.
Cui J; Zhou X; Liu Y; Tang Z
J Cancer Res Clin Oncol; 2001 Sep; 127(9):577-81. PubMed ID: 11570580
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the expression of beta-catenin in hepatocellular carcinoma in areas with high and low levels of exposure to aflatoxin B1.
Chen Ban K; Singh H; Krishnan R; Fong Seow H
J Surg Oncol; 2004 Jun; 86(3):157-63. PubMed ID: 15170655
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma.
Kondo Y; Kanai Y; Sakamoto M; Genda T; Mizokami M; Ueda R; Hirohashi S
Jpn J Cancer Res; 1999 Dec; 90(12):1301-9. PubMed ID: 10665646
[TBL] [Abstract][Full Text] [Related]
9. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
10. Abnormal beta-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China.
Cui J; Zhou XD; Liu YK; Tang ZY; Zile MH
World J Gastroenterol; 2001 Aug; 7(4):542-6. PubMed ID: 11819825
[TBL] [Abstract][Full Text] [Related]
11. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
[TBL] [Abstract][Full Text] [Related]
12. Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.
Okabe H; Kinoshita H; Imai K; Nakagawa S; Higashi T; Arima K; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Ishiko T; Yoshizumi T; Beppu T; Monga SP; Baba H; Maehara Y
PLoS One; 2016; 11(4):e0152695. PubMed ID: 27100093
[TBL] [Abstract][Full Text] [Related]
13. Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma.
Du GS; Wang JM; Lu JX; Li Q; Ma CQ; Du JT; Zou SQ
Ann Surg Oncol; 2009 Jun; 16(6):1578-86. PubMed ID: 19290490
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
[TBL] [Abstract][Full Text] [Related]
15. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
[TBL] [Abstract][Full Text] [Related]
16. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract][Full Text] [Related]
17. Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma.
Jiang Y; Zhou XD; Liu YK; Wu X; Huang XW
World J Gastroenterol; 2002 Oct; 8(5):804-7. PubMed ID: 12378619
[TBL] [Abstract][Full Text] [Related]
18. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
19. Expression of mutant nuclear beta-catenin correlates with non-invasive hepatocellular carcinoma, absence of portal vein spread, and good prognosis.
Mao TL; Chu JS; Jeng YM; Lai PL; Hsu HC
J Pathol; 2001 Jan; 193(1):95-101. PubMed ID: 11169521
[TBL] [Abstract][Full Text] [Related]
20. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC.
Lin ZZ; Jeng YM; Hu FC; Pan HW; Tsao HW; Lai PL; Lee PH; Cheng AL; Hsu HC
BMC Cancer; 2010 Aug; 10():461. PubMed ID: 20799978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]